. 2018 Feb 14;11:13–22. doi: 10.2147/SCCAA.S151763

Table 2.

Effect of donor cell type on in vivo development of horse cloned blastocysts

Groups	Transferred embryos	Recipient mares	Pregnancies (%)	Embryo losses at 0–3 months (%)	Fetal losses at 4–11 months (%)	Deliveries (%)	Viable foals
Groups	Transferred embryos	Recipient mares	Pregnancies (%)	Embryo losses at 0–3 months (%)	Fetal losses at 4–11 months (%)	Deliveries (%)	No.	% per pregnancy	% per delivery
AF	476	232	41 (17.7)^a	19 (46)^a	5 (12.2)^a	17/41 (41.5)^a	9	22.0^a	52.9^a
MSC	594	297	37 (12.5)^a	12 (32.4)^a	4 (10.8)^a	21/37 (56.8)^a	20	54.1^b	95.2^b
AI	88	88	71 (80.7)^b	7 (9.9)^b	0 (0)^b	64/71 (90.1)^b	63	88.7^c	98.4^b

Notes:

^a,b,c

Values with different superscripts in a column are significantly different (Fisher’s exact test p<0.05).

Abbreviations: AF, adult fibroblasts; MSC, mesenchymal stem cell; AI, artificial insemination embryos as controls.